How is the LENZ Therapeutics Inc. today?

The LENZ Therapeutics Inc. today is trading in the down by -1.95% at 29.19.

How has LENZ Therapeutics Inc. performed historically?

The LENZ Therapeutics Inc. is currently trading down -1.95% on an intraday basis in the past week the index fell -0.71%. The index has been up 35.52% in the past quarter and rose 93.57% in the past year. You can view this in the overview section.

What is LENZ Therapeutics Inc. Annual Net Profit?

LENZ Therapeutics Inc. Annual Net Profit rose 28.87% in the last year to $49.77 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is LENZ Therapeutics Inc. Price to Earning Ratio?

LENZ Therapeutics Inc. Price to Earning Ratio is -17.21, which is negative.

What is LENZ Therapeutics Inc. Stock Price?

LENZ Therapeutics Inc. Stock Price rose 93.57% and outperformed its sector by 65.13% in the past year.

What is LENZ Therapeutics Inc. Quarterly Net profit?

LENZ Therapeutics Inc. Quarterly Net profit rose 12.19% YoY to $14.62 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is LENZ Therapeutics Inc. Debt to Equity Ratio?

LENZ Therapeutics Inc. Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is LENZ Therapeutics Inc. Return on Equity(ROE)?

LENZ Therapeutics Inc. Return on Equity(ROE) for the last financial year was -89.37%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is LENZ Therapeutics Inc. Mutual Fund Holding?

LENZ Therapeutics Inc. Mutual Fund Holding increased by 0.81% in the last quarter to 18.16.

What is LENZ Therapeutics Inc. Institutional Holding?

LENZ Therapeutics Inc. Institutional Holding increased by 0.63% in the last quarter to 72.68.

LENZ Therapeutics Inc. XNAS: LENZ

LENZ Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: LENZ Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: LENZ Therapeutics Inc.
Rating: 1.36583325
Author: Trendlyne DVM scores

about

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable...

29.19 -0.58 (-1.95%)

25.02% Fall from 52W High

83,329 XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for LENZ Therapeutics Inc. is on 10 Jun 2025 for the purpose of LENZ Therapeutics Inc Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

4.8 / 100

Technically Neutral

49.8 / 100

No estimates available

LENZ Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

LENZ Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable...

25.02% Fall from 52W High

SWOT Analysis

LENZ Therapeutics Inc. Live Price Chart

LENZ Therapeutics Inc. FAQ

How is LENZ Therapeutics Inc. today?

LENZ Therapeutics Inc. today is trading in the red, and is down by -1.95% at 29.19.

How has LENZ Therapeutics Inc. performed historically?

LENZ Therapeutics Inc. is currently trading down -1.95% on an intraday basis. In the past week the stock fell -0.71%. stock has been up 35.52% in the past quarter and rose 93.57% in the past year. You can view this in the overview section.